Research Reports in Clinical Cardiology最新文献

{"title":"Recurrent pericarditis: current challenges and future prospects","authors":"C. Dauphin, É. Merlin, A. Chalard, R. Trésorier, J. Lusson, M. Soubrier","doi":"10.2147/RRCC.S87827","DOIUrl":"https://doi.org/10.2147/RRCC.S87827","url":null,"abstract":"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). Research Reports in Clinical Cardiology 2016:7 99–108 Research Reports in Clinical Cardiology Dovepress","PeriodicalId":42306,"journal":{"name":"Research Reports in Clinical Cardiology","volume":"7 1","pages":"99-108"},"PeriodicalIF":0.4,"publicationDate":"2016-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/RRCC.S87827","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68476261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transcatheter left atrial appendage occlusion: patient selection and perspectives","authors":"W. Wąsek","doi":"10.2147/RRCC.S83325","DOIUrl":"https://doi.org/10.2147/RRCC.S83325","url":null,"abstract":"and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). Research Reports in Clinical Cardiology","PeriodicalId":42306,"journal":{"name":"Research Reports in Clinical Cardiology","volume":"74 1","pages":"91-97"},"PeriodicalIF":0.4,"publicationDate":"2016-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/RRCC.S83325","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68476212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Frequency of coronary artery stenosis in patients with asymptomatic familial hypercholesterolemia and its association with carotid intimal thickness and cardio-ankle vascular index [Corrigendum]","authors":"Masayo Suzuki, Mao Takahashi, T. Iizuka, H. Terada, H. Noike, K. Shirai","doi":"10.2147/RRCC.S135981","DOIUrl":"https://doi.org/10.2147/RRCC.S135981","url":null,"abstract":"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). Frequency of coronary artery stenosis in patients with asymptomatic familial hypercholesterolemia and its association with carotid intimal thickness and cardio-ankle vascular index","PeriodicalId":42306,"journal":{"name":"Research Reports in Clinical Cardiology","volume":"8 1","pages":"19-20"},"PeriodicalIF":0.4,"publicationDate":"2016-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/RRCC.S135981","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68470924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Guideline-recommended therapy, including beta-blocker utilization, in patients with chronic heart failure: results from a Canadian community hospital heart function clinic","authors":"M. Heffernan","doi":"10.2147/RRCC.S103537","DOIUrl":"https://doi.org/10.2147/RRCC.S103537","url":null,"abstract":"A comprehensive analysis of beta-blocker utilization and other guideline- recommended therapies for the treatment of chronic heart failure in a Canadian community hospital heart function clinic has not been undertaken and was, therefore, the focus of this study. The proportion of patients who would be potential candidates for ivabridine and sacubitril-valsartan therapy as a result of fulfilling the criteria for enrollment in either the Systolic Heart failure treatment with the I f inhibitor ivabradine Trial (SHIFT) study (left-ventricular ejection fraction (LVEF) .35%, sinus rhythm, New York Heart Association II-IV) or the Prospective Comparison of angiotensin receptor-neprilysin inhibitor (ARNI) with angiotensin-converting enzyme inhibitor (ACEI) to determine impact on global Mortality and Morbidity in Heart Failure (PARADIGM-HF) study (LVEF ,40%, New York Heart Association II-IV, glomerular filtration rate .30 mL/min), was also assessed. A retrospec- tive cross-sectional analysis was carried out in all 371 patients treated in this community heart function clinic for at least a 12-month period. The patients were elderly (mean age 74±13.3 years) and predominately male (61.5%) with symptomatic (82.5%) moderate left-ventricular dysfunction (LVEF 45.4%±15.6%). A substantial proportion of the patients also had a diagnosis of atrial fibril - lation (52.8%). The total use of beta blockers exceeded 87%, while 100% of patients without a documented contraindication or intolerance to a beta blocker received therapy. Adherence to other guideline-recommended pharmacotherapies specifically for heart failure with reduced left ventricular ejection was high: 86.1% of the eligible patients were treated with an ACEI/angiotensin receptor blocker and 61.9% received a mineralcorticoid receptor antagonist. We determined that 13.7% of the complement of this heart function clinic could be expected to benefit from ivabridine therapy based on the results of the SHIFT study. In addition, 28.3% of the clinic patients would be eligible for the initiation of sacubitril-valsartan based on the PARADIGM-HF criteria.","PeriodicalId":42306,"journal":{"name":"Research Reports in Clinical Cardiology","volume":"7 1","pages":"69-81"},"PeriodicalIF":0.4,"publicationDate":"2016-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/RRCC.S103537","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68470143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mitral regurgitation: challenges and solutions","authors":"J. Ejiofor, L. Cohn, T. Kaneko","doi":"10.2147/RRCC.S64141","DOIUrl":"https://doi.org/10.2147/RRCC.S64141","url":null,"abstract":": Since the first mitral valvuloplasty in 1923, the technique of mitral valvuloplasty has matured over the years and now has become the first-line treatment, especially in patients with myxomatous mitral regurgitation (MR). We have highlighted some of the major problems that are encountered with the various etiologies of MR. We believe that repair is always the optimal surgical procedure for any of the above etiologies if it is consistent with a long-term result. However, replacement has shown to be a safer procedure in some instances such as severe functional MR or destructive endocarditis.","PeriodicalId":42306,"journal":{"name":"Research Reports in Clinical Cardiology","volume":"7 1","pages":"61-67"},"PeriodicalIF":0.4,"publicationDate":"2016-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/RRCC.S64141","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68474602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pulmonary vein isolation in the treatment of atrial fibrillation","authors":"Saurabh Kumar, G. Michaud","doi":"10.2147/RRCC.S56549","DOIUrl":"https://doi.org/10.2147/RRCC.S56549","url":null,"abstract":"Atrial fibrillation (AF) is the commonest arrhythmia in humans and is associated with marked reduction in quality of life and an elevated thromboembolic risk. Paroxysmal, persistent, and permanent forms of AF have been recognized. Whilst antiarrhythmic drugs are considered as first-line therapy, the role of catheter ablation is increasing due to its superior efficacy in terms of quality of life and reduction in AF burden. The central paradigm for catheter ablation of AF is that triggers for AF are located near and within the pulmonary veins (PVs), and elec- trical isolation of the PVs from the left atrium forms the cornerstone of most catheter ablation strategies. Whilst paroxysmal form is generally trigger dependent, persistent and permanent forms are associated with variable interaction between triggers and \"substrate\" comprised of atrial and PV electrical and structural remodeling. Nevertheless, isolation of the PVs still forms a critical component of catheter ablation strategies, regardless of AF type. Procedural efficacy, however, is limited by PV conduction recovery. This is likely due to deficiencies in ablation tools or limitations of intraprocedural assessment of lesion efficacy. Careful attention to sur - rogates of tissue heating, such as impedance decrease and electrogram morphology changes, along with advances in catheter technology like contact force catheters may improve rates of durable PV isolation and single-procedural success. This review discusses the mechanism of paroxysmal AF with particular focus on the role of the PVs in AF initiation and PV isolation in the management of AF.","PeriodicalId":42306,"journal":{"name":"Research Reports in Clinical Cardiology","volume":"7 1","pages":"47-60"},"PeriodicalIF":0.4,"publicationDate":"2016-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/RRCC.S56549","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68474936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diagnostic usefulness of myocardial perfusion imaging in patients reluctant to undergo angiography","authors":"A. Narang, Amita Singh, Amit R. Patel","doi":"10.2147/RRCC.S75901","DOIUrl":"https://doi.org/10.2147/RRCC.S75901","url":null,"abstract":"Patients with known or suspected coronary artery disease are often referred for isch- emic testing to aid in risk assessment and guide management when symptoms develop. Invasive coronary angiography and percutaneous intervention are typically reserved for patients with symptoms refractory to medical management. The use of noninvasive modalities with myocardial perfusion imaging is a powerful diagnostic and prognostic tool for patients reluctant to undergo angiography. This review focuses on evaluation of coronary artery disease with myocardial perfusion imaging using single-photon emission computerized tomography, positron emission tomography, myocardial contrast echocardiography, cardiovascular magnetic resonance, and cardiovascular computerized tomography.","PeriodicalId":42306,"journal":{"name":"Research Reports in Clinical Cardiology","volume":"7 1","pages":"35-46"},"PeriodicalIF":0.4,"publicationDate":"2016-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/RRCC.S75901","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68475821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The benefits of drug-eluting stents in the treatment of coronary artery disease","authors":"Sarkis Kiramijyan, Ming W. Liu","doi":"10.2147/RRCC.S54203","DOIUrl":"https://doi.org/10.2147/RRCC.S54203","url":null,"abstract":"© 2016 Kiramijyan and Liu. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). Research Reports in Clinical Cardiology 2016:7 9–25 submit your manuscript | www.dovepress.com Dovepress 9","PeriodicalId":42306,"journal":{"name":"Research Reports in Clinical Cardiology","volume":"7 1","pages":"9-25"},"PeriodicalIF":0.4,"publicationDate":"2016-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/RRCC.S54203","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68474094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hyperkalemia in heart failure patients: current challenges and future prospects","authors":"R. López-Vilella, Herminio Morillas-Climent, D. Plaza-López, Mónica Cebrián-Pinar, I. Sánchez-Lázaro, L. Almenar-Bonet","doi":"10.2147/RRCC.S75680","DOIUrl":"https://doi.org/10.2147/RRCC.S75680","url":null,"abstract":"terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). Research Reports in Clinical Cardiology 2016:7 1–8 Research Reports in Clinical Cardiology Dovepress","PeriodicalId":42306,"journal":{"name":"Research Reports in Clinical Cardiology","volume":"7 1","pages":"1-8"},"PeriodicalIF":0.4,"publicationDate":"2016-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/RRCC.S75680","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68475635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical utility of landiolol for use in coronary CT angiography","authors":"N. Tomizawa, Yayoi K. Hayakawa, Shinichi Inoh, T. Nojo, S. Nakamura","doi":"10.2147/RRCC.S77559","DOIUrl":"https://doi.org/10.2147/RRCC.S77559","url":null,"abstract":"License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php Research Reports in Clinical Cardiology 2015:6 145–152 Research Reports in Clinical Cardiology Dovepress","PeriodicalId":42306,"journal":{"name":"Research Reports in Clinical Cardiology","volume":"59 9 1","pages":"145-152"},"PeriodicalIF":0.4,"publicationDate":"2015-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/RRCC.S77559","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68475855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}